메뉴 건너뛰기




Volumn 58, Issue 6, 2009, Pages 320-322

Do patients at high risk of Alzheimer's disease benefit from early treatment?

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE;

EID: 67649622948     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note
Times cited : (4)

References (15)
  • 1
    • 0036075230 scopus 로고    scopus 로고
    • Cost-effective recognition and diagnosis of dementia
    • Geldmacher DS. Cost-effective recognition and diagnosis of dementia. Semin Neurol. 2002;22:63-70. (Pubitemid 34792771)
    • (2002) Seminars in Neurology , vol.22 , Issue.1 , pp. 63-70
    • Geldmacher, D.S.1
  • 3
    • 67649634315 scopus 로고    scopus 로고
    • What are the effects of treatments on cognitive symptoms of dementia?
    • Warner J, Butler R, Wuntakal B. What are the effects of treatments on cognitive symptoms of dementia? BMJ Clin Evid. 2008;01:1001-1028.
    • (2008) BMJ Clin Evid , vol.1 , pp. 1001-1028
    • Warner, J.1    Butler, R.2    Wuntakal, B.3
  • 8
    • 27144538784 scopus 로고    scopus 로고
    • Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: A double-blind placebo-controlled study
    • Koontz J, Baskys A. Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study. Am J Alzheimers Dis Other Demen. 2005;20:295-302. (Pubitemid 41502371)
    • (2005) American Journal of Alzheimer's Disease and Other Dementias , vol.20 , Issue.5 , pp. 295-302
    • Koontz, J.1    Baskys, A.2
  • 10
    • 33644776510 scopus 로고    scopus 로고
    • Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study
    • DOI 10.1136/bmj.38740.439664.DE
    • Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332:455-459. (Pubitemid 43342043)
    • (2006) British Medical Journal , vol.332 , Issue.7539 , pp. 455-458
    • Ancelin, M.L.1    Artero, S.2    Portet, F.3    Dupuy, A.-M.4    Touchon, J.5    Ritchie, K.6
  • 12
    • 67649614973 scopus 로고    scopus 로고
    • Pharmacological treatment of dementia
    • Evidence Report/Technology Assessment No. 97 (prepared by McMaster University Evidence-based Practice Center under Contract No. 290-02-0020). Rockville, MD: Agency for Healthcare Research and Quality; April
    • Santaguida PS, Raina P, Booker L, et al. Pharmacological treatment of dementia. Evidence Report/Technology Assessment No. 97 (prepared by McMaster University Evidence-based Practice Center under Contract No. 290-02-0020). AHRQ Publication No. 04-E019-2. Rockville, MD: Agency for Healthcare Research and Quality; April 2004.
    • (2004) AHRQ Publication No. 04-E019-2
    • Santaguida, P.S.1    Raina, P.2    Booker, L.3
  • 14
    • 0037844484 scopus 로고    scopus 로고
    • Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force
    • Boustani M, Peterson B, Hanson L et al. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:927-937. (Pubitemid 38124636)
    • (2003) Annals of Internal Medicine , vol.138 , Issue.11
    • Boustani, M.1    Peterson, B.2    Hanson, L.3    Harris, R.4    Lohr, K.N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.